Elsevier

Human Pathology

Volume 27, Issue 8, August 1996, Pages 839-847
Human Pathology

Original contribution
Pathology of cryptococcal meningoencephalitis: Analysis of 27 patients with pathogenetic implications

https://doi.org/10.1016/S0046-8177(96)90459-1Get rights and content

Abstract

In this autopsy series of cryptococcal meningoencephalitis (CME), the authors analyzed neuropathologic lesions in 13 human immunodeficiency virus (HIV) and 14 non-HIV-related cases. Most non-HIV patients did not have immunosuppressive predisposing illness. Analysis of pathological findings revealed significant differences in the inflammatory response to CME in patients with and without HIV infection. None of the acquired immunodeficiency syndrome (AIDS) patients had granulomatous inflammation, whereas most non-HIV-associated cases had granulomas, supporting a role for cell-mediated immunity in CME. Lymphocytic infiltrate in both groups consisted of T cells (CD45RO+). In some non-HIV-associated cases, CME was undiagnosed and untreated. In most HIV-associated cases, CME had an encephalitic component, resulting in grossly or microscopically visible accumulations of fungi within the brain parenchyma, whereas in non-HIV-associated cases, CME was often confined to the subarachnoid space and large perivascular spaces (Virchow-Robin spaces). In non-HIV-associated cases, yeast forms were fewer and showed a more limited distribution. In contrast, many extracellular fungi were present in many cases of HIV-associated CME. The principal reactive cell in CME in AIDS was brain macrophages and microglia, especially those in the perivascular and juxtavascular locations. Reactive astrocytes were limited to large destructive lesions and subpial regions. In several patients with HIV-associated CME, large parenchymal cryptococcomas contained Crytococcus neoformans (CN) with cell wall pigmentation, suggestive of melanin. The authors suggest that in AIDS patients altered immune functions allow CN to accumulate within the brain, predominantly extracellularly, and that deficient macrophage/microglial effector function may be responsible for the altered pathology. In addition, coexisting CNS processes in HIV-associated CME may contribute to the altered pathology. The authors conclude that cryptococcal meningitis is not a disease limited to the cerebrospinal fluid (CSF) space but affects the brain more significantly than suspected. Therapeutic strategies that enhance the effector function of glial cells at the CNS-CSF barrier may be useful for improving the response to therapy.

References (24)

  • SC Lee et al.

    Induction of nitric oxide synthase activity in human astrocytes by IL-β and IFN-y

    J Neuroimmunol

    (1993)
  • SC Lee et al.

    Interleukin-1, nitric oxide and reactive astrocytes

    Brain Behav Immun

    (1995)
  • M Pettoello-Mantovani et al.

    Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans

    Lancet

    (1992)
  • BP Currie et al.

    Estimation of the prevalence of cryptococcal infection among HIV infected individuals in New York City

    Clin Infect Dis

    (1994)
  • KH Anders et al.

    The neuropathology of AIDS: UCLA experience and review

    Am J Pathol

    (1986)
  • J Artigas et al.

    Neuropathology of AIDS

  • RD Diamond

    Cryptococcosis neoformans

  • K Kure et al.

    Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method

    Am J Pathol

    (1990)
  • SC Lee et al.

    Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis

    Am J Pathol

    (1996)
  • H Budka et al.

    HIV-associated disease of the nervous system: Review of nomenclature and proposal for neuropathology-based terminology

    Brain Pathol

    (1991)
  • M Edelman et al.

    Microglial nodule encephalitis: Limited CNS infection despite disseminated systemic cryptococcosis

    Clin Neuropathol

    (1996)
  • O Lazcano et al.

    Combined FontanaMasson-Mucin staining of Cryptococcus neoformans

    Arch Pathol Lab Med

    (1991)
  • Cited by (0)

    Supported by National Institute of Health grants NIMH 47667 (SCL and DWD), and AI33774 and AI13342 (AC).

    View full text